Life Sciences

FDA Approves First Drug for Rare Mitochondrial Disease TK2d
Public Policy FDA Approves First Drug for Rare Mitochondrial Disease TK2d

Today, we’re diving into the groundbreaking world of mitochondrial disease treatments with Faisal Zain, a renowned healthcare expert specializing in medical technology. With his extensive experience in the development and manufacturing of cutting-edge medical devices, Faisal offers a unique p

How Will Thermo Fisher's $9B Clario Deal Boost Biopharma?
Business How Will Thermo Fisher's $9B Clario Deal Boost Biopharma?

I'm thrilled to sit down with Faisal Zain, a seasoned healthcare expert with a deep focus on medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has a unique perspective on innovation in the biopharmaceutical industry.

GSK Expands COPD Pipeline with $85M Drug Acquisition
Care GSK Expands COPD Pipeline with $85M Drug Acquisition

In a landscape where chronic respiratory diseases continue to burden millions globally, a staggering statistic reveals that chronic obstructive pulmonary disease (COPD) ranks as one of the leading causes of death worldwide, affecting over 300 million people. This pressing health challenge has

Can AI Unlock Nature’s Secrets to Drug Elusive Proteins?
Technology Can AI Unlock Nature’s Secrets to Drug Elusive Proteins?

What if the key to curing some of humanity’s deadliest diseases lies hidden in proteins that science has long deemed impossible to target? In the realm of drug discovery, a staggering number of proteins—implicated in conditions like cancer and autoimmune disorders—remain out of reach for modern medi

Adaptam Therapeutics Secures Funding for Cancer Breakthrough
Care Adaptam Therapeutics Secures Funding for Cancer Breakthrough

Pioneering a Shift in Cancer Treatment Strategies In the ever-evolving landscape of oncology, a staggering reality persists: a significant number of patients with solid tumors remain unresponsive to current immunotherapies, highlighting a critical gap in effective treatment options. Adaptam

How Are Cell and Gene Therapies Shaping New Market Trends?
Care How Are Cell and Gene Therapies Shaping New Market Trends?

In a world where chronic diseases burden millions and healthcare systems strain under the weight of an aging population, a quiet revolution is unfolding with cell and gene therapies at its core. Once mere concepts in scientific journals, these therapies are now delivering cures for conditions long

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later